PMV Pharmaceuticals, Inc. (PMVP) › Shareholders' EquityPMV Pharmaceuticals, Inc. (PMVP) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: -$29.73M2018: -$46.14M2019: -$70.47M2020: $359.12M2021: $308.56M2022: $246.03M2023: $225.69M2024: $176.08M2025: $104.71M$104.71M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$104.71M-40.5%2024$176.08M-22.0%2023$225.69M-8.3%2022$246.03M-20.3%2021$308.56M-14.1%2020$359.12M+609.6%2019-$70.47M-52.7%2018-$46.14M-55.2%2017-$29.73M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share